Sun Pharma and Pharmazz Inc. enter into licensing agreement for introducing Tyvalzi™ (Sovateltide) in India

Sun Pharma Canada Launches PR WINLEVI® (clascoterone cream 1% w/w), a Novel Topical Treatment for Acne Source link

Sun Pharma to announce first quarter results on August 03, 2023 Source link

Sun Pharma launches nationwide initiative, #SecondBirthDate on National Doctor’s Day Source link

ADA GL0034 Data Release Source link

Sun Pharma Announces Health Canada Approval of PRWINLEVI® (clascoterone cream 1%) for Topical Treatment of Acne Source link

Sun Pharma Announces China NMPA Approval For ILUMETRI (Tildrakizumab Injection) For Treatment Of Adults with Moderate-To-Severe Plaque Psoriasis Source link